If in non-pacemaker cells: Role and pharmacological implications
Introduction
Pacemaker ionic channels help to endow some types of specialized cells (either cardiomyocytes, neurons, or smooth muscle cells) with an intrinsic rhythmic activity. In the mammalian cardiac sinus node, the pacemaker current, termed If, plays a crucial physiological role in setting the heart rate and sensing its autonomic control (see [1] in this issue). The role of f-channels in non-pacemaker cardiac cells has long been disregarded. This flaw was based on the assumption that If expression is limited to the sinus node region and other parts of the conduction system, i.e., those cells possessing a well-defined diastolic depolarization phase. This conviction was also fueled by the lack of molecular assays, since genes coding for f-channels have been cloned only recently. Notwithstanding this view, first electrophysiological and then molecular data demonstrated that HCN channels are also present in non-pacemaker tissues. In our laboratory, the hypothesis of a “pacemaker” current in ventricular cells arose from the observation of a clear-cut diastolic depolarization phase during intracellular recordings from papillary muscles of hypertrophied rat hearts [2]. Two facts excluded the interpretation of this phenomenon as an experimental artifact: first, diastolic depolarization was absent in non-hypertrophied muscles challenged with similar experimental conditions. Second, and most important, this diastolic depolarization phase was prone to be steepened by β-adrenoceptor (βAR) stimulation, which exerted – in the hypertrophied ventricular tissue namely – a striking proarrhythmic action [2]. As reviewed in the previous article by DiFrancesco [1], the autonomic control of heart rate in pacemaker cells is largely mediated by the presence of the funny current If which is specifically modulated by intracellular cAMP levels. Thus, we postulated that the sensitivity to catecholamines and the presence of a diastolic depolarization were due to an atypical If occurrence in diseased ventricular tissue. This article will review the present knowledge concerning the presence and pharmacological modulation of If in common ventricular and atrial myocytes.
Section snippets
If in non-pacemaker cardiac cells
In ventricular myocytes, If is abundantly expressed during fetal and neonatal life [3], [4], [5]. Moreover, in murine beating myocytes derived from embryonic stem cells (ESC), If is detected early during differentiation [6]. At some stage of their in situ (or in vitro, for ESC-derived cardiomyocytes) electrophysiological maturation toward adult ventricular phenotype, these cells lose their capacity to generate spontaneous activity. Both in mouse and rat hearts, this is accompanied by a
Biophysical and pharmacological properties of ventricular If
By definition, pacemaker channels are non-selective ionic channels, blocked by a millimolar concentration of cesium applied extracellularly. These are distinctive features of ventricular If, too. In fact, Fig. 3A and B demonstrates that the reversal potential, calculated by tail current analysis, is about −20 mV, matching a channel with mixed conductance for Na and K ions (PNa/PK ≈ 0.25), and that the current is completely blocked by extracellular cesium (Fig. 3B and inset). Channel selectivity (P
If as a marker of cardiac remodeling
Mislocalized expression and/or overexpression of cardiac HCN channels may represent an example of a general phenomenon, termed cardiac remodeling, which consists namely in the re-expression of fetal proteins [31]. The renin–angiotensin system plays a pivotal role in ventricular remodeling (for a review, see [32]). The chronic activation in this system, as occurs in hypertension, ischemic cardiomyopathy, diabetes, and many other cardiovascular diseases, results in an overproduction of
If inhibitors in non-pacemaker cells
If expression in non-pacemaker cells may have pharmacological and therapeutic implications. Among many well-known mechanisms, the efficacy of some drugs routinely used in ischemic cardiomyopathy or heart failure in reducing cardiac death, might be speculatively ascribed to a reduced If expression (ACE inhibitors, AT1 antagonists) or blockade of catecholamine action on this current (β-blockers). Selective 5-HT4 antagonists demonstrated antiarrhythmic properties in a pig model of atrial
Conclusions
Molecular identification of HCN subunits and their functional/molecular detection in the diseased ventricle attracted novel and unforeseen attention to pacemaker channels. In addition to the acute regulation of pacemaker currents, which adjusts beat-to-beat cardiac rate, long-term stimuli involved in cardiac remodeling can profoundly alter the properties of If in cardiomyocytes. Although the regulatory pathways which control f-channel expression remain to be elucidated, this phenomenon involves
Acknowledgments
Our original work was supported by grants from the Ministry of Education, University and Research and from Telethon.
References (57)
Funny channels in the control of cardiac rhythm and mode of action of selective blockers
Pharmacol Res
(2006)- et al.
Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats
J Mol Cell Cardiol
(1994) - et al.
Isolated cardiac cells for electropharmacological studies
Pharmacol Res
(2000) - et al.
Functional remodeling in post-myocardial infarcted rats: Focus on beta-adrenoceptor subtypes
J Mol Cell Cardiol
(2006) - et al.
The properties of the pacemaker current If in human ventricular myocytes are modulated by cardiac disease
J Mol Cell Cardiol
(2001) - et al.
Cardiac HCN channels: structure, function, and modulation
Trends Cardiovasc Med
(2002) - et al.
Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain
Cell
(1998) - et al.
Angiotensin II induces apoptosis of adult ventricular myocytes in vitro
J Mol Cell Cardiol
(1997) - et al.
The electrophysiological effects of acetylcholine in single human atrial cells
J Mol Cell Cardiol
(1987) - et al.
A hyperpolarization-activated inward current in human myocardial cells
J Mol Cell Cardiol
(1992)
Pharmacological modulation of the hyperpolarization-activated current (If) in human atrial myocytes: focus on G protein-coupled receptors
J Mol Cell Cardiol
Influence of postnatal-development on if occurrence and properties in neonatal rat ventricular myocytes
Cardiovasc Res
If current and spontaneous activity in mouse embryonic ventricular myocytes
Circ Res
Developmental change in the voltage-dependence of the pacemaker current, If, in rat ventricle cells
Pflugers Arch
Functional expression and regulation of the hyperpolarization activated non-selective cation current in embryonic stem cell-derived cardiomyocytes
J Physiol (London)
Characterization of the hyperpolarization-activated current, If, in ventricular myocytes isolated from hypertensive rats
J Physiol (London)
Occurrence and properties of the hyperpolarization-activated current If in ventricular myocytes from normotensive and hypertensive rats during aging
Circulation
Myocardial remodeling and arrhythmogenesis in moderate cardiac hypertrophy in rats
Am J Physiol Heart Circ Physiol
Regional distribution of hyperpolarization-activated current If and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts
J Physiol (London)
Characterization of the hyperpolarization-activated current, If, in ventricular myocytes from human failing heart
Circulation
Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts
Circulation
A family of hyperpolarization-activated mammalian cation channels
Nature
Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues
Circ Res
Thyroid hormone regulates hyperpolarization-activated cyclic nucleotide-gated channel (HCN2) mRNA in the rat heart
Circ Res
The hyperpolarization-activated current If in ventricular myocytes of non-transgenic and beta2-adrenoceptor overexpressing mice
Naunyn Schmiedebergs Arch Pharmacol
Hallmarks of ion channel gene expression in end-stage heart failure
FASEB J
Molecular basis of funny current (If) in normal and failing human heart
Circulation
Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure
Cardiovasc Res
Cited by (54)
Notch1-mediated histone demethylation of HCN4 contributes to aconitine-induced ventricular myocardial dysrhythmia
2020, Toxicology LettersCitation Excerpt :Both of these two alterations in NRVMs, which have been directly implicated in ventricular arrhythmia, imply that aconitine thereby may increase the arrhythmogenic risk by enhancing If current of ventricular cardiomyocytes after repeated administration for some time. As a distinctive feature of autorhythmic cells, If current is mainly carried through HCN4 channel and lacks in mature cardiac working cells (Cerbai and Mugelli, 2006; Herrmann et al., 2012). An unexpected enhance in If current recorded in aconitine-treated NRVMs indicates that basic component for this pacemaking current may appear in cells.
Ivabradine and metoprolol in fixed dose combination: When, why and how to use it
2019, Pharmacological ResearchMechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells
2015, Journal of Molecular and Cellular CardiologyCitation Excerpt :One possible mechanism is that an inward current generated by If is responsible for a slow diastolic depolarization and when the voltage reaches the threshold potential of L-type Ca2 + channels, the activation of ICa,L initiates a ‘Ca2 +’ action potential and automaticity. The HCN family, which encodes for If, are not only expressed in SA node cells but are prominently found in ventricular myocytes of newborn rat hearts and in pathological conditions such as mild to severe hypertrophy and following myocardial infarction [53–55]. In human ventricular myocytes, HCN4 and HCN2 mRNA levels are readily detected (HCN4 > HCN2) but the funny current, If is barely detectable, except in hypertrophic ventricular myocytes where mRNA and If are markedly upregulated [53,56].
Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues
2013, Pharmacology and TherapeuticsCitation Excerpt :A more intriguing possibility is that electrical remodelling of the myocardium in the syndrome of heart failure leads to upregulation of If outside of the cardiac conduction system, which then acts as an arrhythmogenic substrate (Song et al., 2011). It is well established that electrical remodelling of ventricular myocardium occurs in hypertension, heart failure and following myocardial infarction; furthermore it has been demonstrated that If is upregulated as part of this process (Cerbai et al., 1994, 1996, 2001; Cerbai & Mugelli, 2006; Stillitano et al., 2008; Xia et al., 2010). Prevention of electrical remodelling following myocardial infarction by established therapies such as ACE inhibitors may include reduction of the upregulation of If, providing a mechanism for suppression of arrhythmia by pharmacological therapy that is not primarily antiarrhythmic (Song et al., 2011).
Electrophysiologic considerations in congenital heart disease and their relationship to heart failure
2013, Canadian Journal of Cardiology